Serum samples from 108 unselected Jamaican patients with homozygous sickle cell disease and 116 control subjects with normal haemoglobin were screened for the presence of antiphospholipid antibodies.
Antiphospholipid antibodies are known to be associated with repeated episodes of arterial or venous thrombosis, or both, recurrent fetal loss, neurological disease, and possible thrombocytopenia. ' 2 In patients with homozygous sickle cell disease, spontaneous abortions occur in up to 24% of pregnancies.3 Central nervous system lesions also often occur, especially hemiplegia, convulsions, and brain stem ischaemia.4 5 Most of these clinical complications may be explained by small blood vessel obstruction by sickle erythrocytes. However, the wide variability of the clinical spectrum of sickle cell disease necessitates consideration of other possible mechanisms. Repeated sickling produces a disruption and rearrangement of red cell membranes. 6 The exposure of negatively charged phospholipids may result in the induction of antibodies against these cell membrane constituents. Therefore, we screened a large number of patients with sickle cell disease and control subjects with normal haemoglobin for the presence of antiphospholipid antibodies. 
Results
Of the 108 patients with sickle cell disease nine (8%) had increased levels of IgG antiphospholipid antibodies (range 5 5-15*6 U IgG); none of the 116 control subjects had increased levels of antiphospholipid antibodies (X2 test, p=0-0018).
In four of the nine patients with positive sickle cell disease, frozen serum samples from previous years were available; all were positive 16 Systemic lupus erythematosus may be more common in sickle cell disease than in the general population."' The patients with sickle cell disease with increased levels of antiphospholipid antibodies did not show signs of nephritis, arthritis, skin rashes, or other features of a connective tissue disease, however. Also, none of these patients was positive for antibodies to ENA or dsDNA.
Whatever the aetiopathogenesis of antiphospholipid antibodies in sickle cell disease, patients with sickle cell disease with these antibodies did not show any more serious disease course than patients with sickle cell disease without antiphospholipid antibodies. The haemolytic rate also appeared to be similar in the two groups. This is in agreement with the observation that antiphospholipid antibodies induce complications only at levels much higher than those observed in sickle cell disease.
In conclusion, this study provides further evidence that the high levels of antiphospholipid antibodies found in patients with systemic lupus erythematosus and other connective tissue disorders, but not found in patients with sickle cell disease, are not merely secondary to cell breakdown.
